Forbindelser med HIV-proteaseaktivitet, farmasøytisk preparat derav og anvendelse derav ved fremstillingen av et medikament for behandling eller forebyggelse av symptomene eller virkningene av HIV-infeksjon

Phosphonate substituted compounds with HIV protease inhibitory properties having use as therapeutics and for other industrial purposes are disclosed. The compositions inhibit HIV protease activity and/or are useful therapeutically for the treatment of AIDS and other antiviral infections, as well as...

Full description

Saved in:
Bibliographic Details
Main Authors YU RICHARD H, DASTGAH AZAR, ZHANG JIANCUM, YANG ZHENG-YU, LEE WILLIAM A, ARIMILLI MURTY N, XU LIANHONG, CHEN JAMES M, TARIO JAMES D, BRYANT CLIFFORD M, PYUN HYUNG-JUNG, MACKMAN RICHARD L, HE GONG-XIN, WANG JIANYING, FARDIS MARIA, SWAMINATHAN SUNDARAMOORTHI, BECKER MARK M, WILLIAMS MATTHEW A, NELSON PETER HAROLD, LIU HONGTAO, MITCHELL MICHAEL L, JIN HAOLUN, ZHANG LIJUN, LIN KUEI-YING, KIM CHOUNG U, CHEN XIAOWU, ROWE TANISHA D, LEE CHRISTOPHER P, SPARACINO MARK L
Format Patent
LanguageNorwegian
Published 31.08.2015
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Phosphonate substituted compounds with HIV protease inhibitory properties having use as therapeutics and for other industrial purposes are disclosed. The compositions inhibit HIV protease activity and/or are useful therapeutically for the treatment of AIDS and other antiviral infections, as well as in assays for the detection of HIV protease.
Bibliography:Application Number: NO20040005150